Market Exclusive

WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) Files An 8-K Regulation FD Disclosure

WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) Files An 8-K Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure.

On December 14, 2016, West Pharmaceutical Services, Inc. (the
“Company”) announced that its Board of Directors has approved a
first-quarter 2017 dividend of $0.13 per share. The dividend will
be paid on February 1, 2017 to shareholders of record as of
January 18, 2017.
The information contained in Item 7.01 of this report and Exhibit
99.1 is being furnished and shall not be deemed “filed” for
purpose of Section 18 of the Securities Exchange Act of 1934, as
amended (“Exchange Act”), or otherwise subject to the
liabilities of that section, nor will it be incorporated by
reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as expressly set forth by
specific referencing in such filing.
A copy of the press release issued by the Company is attached
hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 8.01 Other Events.
Also on December 14, 2016, the Company announced a share
repurchase program authorizing the repurchase of up to 800,000
shares of the Company’s common stock from time to time on the
open market or in privately-negotiated transactions as permitted
under Exchange Act Rule 10b-18. The number of shares to be
repurchased and the timing of such transactions will depend on a
variety of factors, including market conditions, but the program
will commence on January 1, 2017 and is expected to be completed
by December 31, 2017. The Company’s previously-authorized share
repurchase program expires on December 31, 2016.
Item 9.01 Financial Statements and Exhibits.
(d)
Exhibits
Exhibit 99.1
West Pharmaceutical Services, Inc. Press Release, dated
December 14, 2016.

About WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST)
West Pharmaceutical Services, Inc. (West) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. The Company’s segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems). Its Packaging Systems segment includes primary packaging components and systems for injectable drug delivery, other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. Its Delivery Systems segment includes safety and administration systems, multi-component systems for drug containment and administration and various custom contract-manufacturing solutions. WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) Recent Trading Information
WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) closed its last trading session up +0.09 at 84.57 with 318,400 shares trading hands.

Exit mobile version